Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New therapies for clear cell ovarian carcinoma
James Stewart, Niamh Cunningham, Susana Banerjee
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 385-393
Open Access | Times Cited: 10

Showing 10 citing articles:

From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer
Zesi Liu, Chunli Jing, Fandou Kong
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Application of interpretable machine learning algorithms to predict distant metastasis in ovarian clear cell carcinoma
Qin‐Hua Guo, Feng‐Chun Xie, Fangmin Zhong, et al.
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 5
New windows of surgical opportunity for gynecological cancers in the era of targeted therapies
Inge Peters, Cláudia Marchetti, Giovanni Scambia, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 3, pp. 352-362
Open Access | Times Cited: 4
Glycogen stores mediated by the p53-GYS1 feedback circuit engenders platinum resistance in ovarian clear cell carcinoma
Haoyu Liang, Rongzhen Luo, Ru Deng, et al.
Cell Death and Differentiation (2025)
Closed Access
Novel therapies leading to a new landscape in gynecologic tumors
Ainhoa Madariaga, Robert L. Coleman, Antonio González‐Martín
International Journal of Gynecological Cancer (2023) Vol. 33, Iss. 3, pp. 321-322
Open Access | Times Cited: 4
Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
Blair McNamara, Stefania Bellone, Cem Demirkiran, et al.
Gynecologic Oncology Reports (2023) Vol. 48, pp. 101218-101218
Open Access | Times Cited: 4
Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
Min Yin, Chunli Lu, Huimei Zhou, et al.
BMC Women s Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Fibroblast Growth Factor 11 (FGF11) Promotes Progression and Cisplatin Resistance Through the HIF-1α/FGF11 Signaling Axis in Ovarian Clear Cell Carcinoma
Min Yin, Chunli Lu, Huimei Zhou, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 753-763
Open Access | Times Cited: 2
Functional validation of somatic variability in TP53 and KRAS for prediction of platinum sensitivity and prognosis in epithelial ovarian carcinoma patients
Mohammad Al Obeed Allah, Esraa Ali, Ivona Krus, et al.
Research Square (Research Square) (2024)
Open Access
SOX17 expression in ovarian clear cell carcinoma
Daichi Kodama, Motoki Takenaka, Chiemi Saigo, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access
Page 1

Scroll to top